Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.37 USD | +15.07% | +18.49% | -17.30% |
Business Summary
Number of employees: 1,774
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Precision Oncology Testing
91.2
%
| 392 | 87.2 % | 514 | 91.2 % | +31.17% |
Development Services and Other
8.8
%
| 57 | 12.8 % | 50 | 8.8 % | -13.55% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
93.4
%
| 421 | 93.6 % | 527 | 93.4 % | +25.18% |
International
6.6
%
| 29 | 6.4 % | 37 | 6.6 % | +29.41% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Wiley
FOU | Founder | 48 | 11-12-31 |
AmirAli Talasaz
FOU | Founder | 44 | 11-12-31 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 45 | 12-12-31 |
Michael Bell
DFI | Director of Finance/CFO | 55 | 21-01-04 |
Andrew Ament
COO | Chief Operating Officer | - | - |
Darya Chudova
CTO | Chief Tech/Sci/R&D Officer | - | 15-07-31 |
Craig Eagle
CTO | Chief Tech/Sci/R&D Officer | 57 | 21-05-02 |
Kumud Kalia
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-01-20 |
Alex Kleban
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | 50 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
BRD | Director/Board Member | 62 | 16-11-30 |
Myrtle Potter
BRD | Director/Board Member | 65 | 21-10-14 |
Vijaya Gadde
BRD | Director/Board Member | 49 | 20-05-31 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 45 | 12-12-31 |
Steve Krognes
BRD | Director/Board Member | 56 | 22-06-29 |
AmirAli Talasaz
FOU | Founder | 44 | 11-12-31 |
Musa Tariq
BRD | Director/Board Member | 41 | 23-03-05 |
Meghan Joyce
BRD | Director/Board Member | 39 | 21-08-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 122,369,214 | 116,347,108 ( 95.08 %) | 0 | 95.08 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LUNIT INC. 5.39% | 1,550,000 | 5.39% | 67,929,432 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.30% | 2.74B | |
-27.67% | 9.87B | |
+34.87% | 3.07B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M | |
+12.46% | 219M |
- Stock Market
- Equities
- GH Stock
- Company Guardant Health, Inc.